Comparing the efficacy of concurrent EGFR-TKI and whole-brain radiotherapy vs EGFR-TKI alone as a first-line therapy for advanced EGFR-mutated non-small-cell lung cancer with brain metastases: a retrospective cohort study

Comparing the efficacy of concurrent EGFR-TKI and whole-brain radiotherapy vs EGFR-TKI alone as a first-line therapy for advanced EGFR-mutated non-small-cell lung cancer with brain metastases: a retrospective cohort study

Zhi-Yong He,1,2,* Mei-Fang Li,1,2,* Jing-Hui Lin,1,2 Dong Lin,1,2 Ren-Jang Lin3 1Department of Thoracic Medical Oncology, Fujian Cancer Hospital, Fujian Medical University Cancer Hospital, Fuzhou 350014, Fujian Province, People’s Republic of China; 2Fujian Provincial Key Laboratory of Tran...

Full description

Bibliographic Details
Main Authors: He ZY, Li MF, Lin JH, Lin D, Lin RJ
Format: Article
Language:English
Published: Dove Medical Press 2019-03-01
Series:Cancer Management and Research
Subjects:
non-small-cell lung cancer
brain metastasis
epidermal growth factor receptor
tyrosine kinase inhibitor
whole-brain radiotherapy
Online Access:https://www.dovepress.com/comparing-the-efficacy-of-concurrent-egfr-tki-and-whole-brain-radiothe-peer-reviewed-article-CMAR

Internet

https://www.dovepress.com/comparing-the-efficacy-of-concurrent-egfr-tki-and-whole-brain-radiothe-peer-reviewed-article-CMAR

Similar Items